Global HIV/AIDs Diagnostics Market Size study, by Product (Consumables, Instruments and Software & services), by Test Type (Antibody Test, Viral Load Tests, CD4 Test, Test for Early Infant Diagnosis and Tests for Viral Identification), by End-User (Diagnostics Laboratories, Hospitals, Blood Banks, Home care Settings and Others) and Regional Forecasts 2020-2026

  • Product Code:
    RP-ID-10321995
  • Published Date:
    May 2020 (Upgradation in process)
  • Region:
    Global
  • Pages:
    200
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:
    Pub-ID-14

Impact Analysis on the Growth of Market

Activating Probable Propositions Amidst COVID-19 Crisis

With things going haywire, we analyze key points to make sure that the businesses around the globe are completely prepared to tackle potential implications caused by COVID-19. Be it protecting employees, customers or the overall business operations, we ensure that the employers take the right decisions, make strategic investments and maintain a healthy work culture along with taking probable measures to minimize the financial loss. Know More

Global HIV/AIDs Diagnostics Market is valued approximately at USD 3.17 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 10.5% over the forecast period 2019-2026. Human Immunodeficiency Virus (HIV) is a sever virus diseases that attacks body cells which helps in fighting with infection of body and results in making a person more vulnerable to other infections and diseases. It is spread by contact with certain bodily fluids of a person with HIV, most commonly during unprotected intercourse and through sharing injections drug equipment. Whereas, Acquired immune deficiency syndrome (AIDs) is the late stage of HIV infection that occurs when the body’s immune system is badly damaged because of the virus. Thus, to identify symptoms of HIV/AIDs and evaluating the disease to initiate its treatment or curing, diagnosis of HIV/AIDs are essential. The cases of HIV/AIDs across the globe is increasing which is expected to propel the growth of market over the forecast years. For instance: as per the World Health Organization (WHO), globally over 37.9 million people affected with HIV in 2018 and over 23.3 million people were receiving antiretroviral treatment by end 2018. Also, over 62% of people affected with HIV were receiving antiretroviral treatment in 2018. Thus, the increasing prevalence of HIV/AIDs across the globe is expected to drive the growth of market over the forecast years. However, lack of awareness among people regarding HIV/AIDs across the globe is expected to hamper the growth of market over the forecast years.

The regional analysis of global HIV/AIDs Diagnostics market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the increasing cases of HIV/AIDs across the region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026. Factors such as Increasing Number of Blood Transfusions and Blood Donations and favorable government initiatives regarding HIV/AIDs Diagnostics would create lucrative growth prospects for the HIV/AIDs Diagnostics market across Asia-Pacific region.

Major market player included in this report are:
Siemens Healthineers
Roche Diagnostics
Abbott Laboratories
Beckman Coulter, Inc.
Thermo-Fisher Scientific Inc.
Merck KGaA
Becton, Dickinson & Company
Hologic Inc.
Alere Inc.
Bio-Rad Laboratories

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Consumables
Instruments
Software & services

By Test Type:
Antibody Test
Viral Load Tests
CD4 Test
Test for Early Infant Diagnosis
Tests for Viral Identification

By End-User:
Diagnostics Laboratories
Hospitals
Blood Banks
Home care Settings
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017, 2018
Base year – 2019
Forecast period – 2020 to 2026

Target Audience of the Global HIV/AIDs Diagnostics Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Billion)
1.2.1. HIV/AIDs Diagnostics Market, by Region, 2018-2026 (USD Billion)
1.2.2. HIV/AIDs Diagnostics Market, by Product, 2018-2026 (USD Billion)
1.2.3. HIV/AIDs Diagnostics Market, by Test Type, 2018-2026 (USD Billion)
1.2.4. HIV/AIDs Diagnostics Market, by End-User, 2018-2026 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global HIV/AIDs Diagnostics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global HIV/AIDs Diagnostics Market Dynamics
3.1. HIV/AIDs Diagnostics Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global HIV/AIDs Diagnostics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global HIV/AIDs Diagnostics Market, by Product
5.1. Market Snapshot
5.2. Global HIV/AIDs Diagnostics Market by Product, Performance - Potential Analysis
5.3. Global HIV/AIDs Diagnostics Market Estimates & Forecasts by Product 2016-2026 (USD Billion)
5.4. HIV/AIDs Diagnostics Market, Sub Segment Analysis
5.4.1. Consumables
5.4.2. Instruments
5.4.3. Software & services
Chapter 6. Global HIV/AIDs Diagnostics Market, by Test Type
6.1. Market Snapshot
6.2. Global HIV/AIDs Diagnostics Market by Test Type, Performance - Potential Analysis
6.3. Global HIV/AIDs Diagnostics Market Estimates & Forecasts by Test Type 2016-2026 (USD Billion)
6.4. HIV/AIDs Diagnostics Market, Sub Segment Analysis
6.4.1. Antibody Test
6.4.2. Viral Load Tests
6.4.3. CD4 Test
6.4.4. Test for Early Infant Diagnosis
6.4.5. Tests for Viral Identification
Chapter 7. Global HIV/AIDs Diagnostics Market, by End-User
7.1. Market Snapshot
7.2. Global HIV/AIDs Diagnostics Market by End-User, Performance - Potential Analysis
7.3. Global HIV/AIDs Diagnostics Market Estimates & Forecasts by End-User 2016-2026 (USD Billion)
7.4. HIV/AIDs Diagnostics Market, Sub Segment Analysis
7.4.1. Diagnostics Laboratories
7.4.2. Hospitals
7.4.3. Blood Banks
7.4.4. Home care Settings
7.4.5. Others
Chapter 8. Global HIV/AIDs Diagnostics Market, Regional Analysis
8.1. HIV/AIDs Diagnostics Market, Regional Market Snapshot
8.2. North America HIV/AIDs Diagnostics Market
8.2.1. U.S. HIV/AIDs Diagnostics Market
8.2.1.1. Product breakdown estimates & forecasts, 2016-2026
8.2.1.2. Test Type breakdown estimates & forecasts, 2016-2026
8.2.1.3. End-User breakdown estimates & forecasts, 2016-2026
8.2.2. Canada HIV/AIDs Diagnostics Market
8.3. Europe HIV/AIDs Diagnostics Market Snapshot
8.3.1. U.K. HIV/AIDs Diagnostics Market
8.3.2. Germany HIV/AIDs Diagnostics Market
8.3.3. Rest of Europe HIV/AIDs Diagnostics Market
8.4. Asia-Pacific HIV/AIDs Diagnostics Market Snapshot
8.4.1. China HIV/AIDs Diagnostics Market
8.4.2. India HIV/AIDs Diagnostics Market
8.4.3. Japan HIV/AIDs Diagnostics Market
8.4.4. Rest of Asia Pacific HIV/AIDs Diagnostics Market
8.5. Latin America HIV/AIDs Diagnostics Market Snapshot
8.5.1. Brazil HIV/AIDs Diagnostics Market
8.5.2. Mexico HIV/AIDs Diagnostics Market
8.6. Rest of The World HIV/AIDs Diagnostics Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Siemens Healthineers
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Roche Diagnostics
9.2.3. Abbott Laboratories
9.2.4. Beckman Coulter, Inc.
9.2.5. Thermo-Fisher Scientific Inc.
9.2.6. Merck KGaA
9.2.7. Becton, Dickinson & Company
9.2.8. Hologic Inc.
9.2.9. Alere Inc.
9.2.10. Bio-Rad Laboratories
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research AssumptionList of Tables
TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL HIV/AIDS DIAGNOSTICS MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL HIV/AIDS DIAGNOSTICS MARKET
TABLE 3. GLOBAL HIV/AIDS DIAGNOSTICS MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. GLOBAL HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
TABLE 7. GLOBAL HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY PRODUCT 2016-2026 (USD BILLION)
TABLE 8. GLOBAL HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY TEST TYPE 2016-2026 (USD BILLION)
TABLE 9. GLOBAL HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY END-USER 2016-2026 (USD BILLION)
TABLE 10. GLOBAL HIV/AIDS DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 11. GLOBAL HIV/AIDS DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 12. GLOBAL HIV/AIDS DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 13. GLOBAL HIV/AIDS DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 14. GLOBAL HIV/AIDS DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 15. GLOBAL HIV/AIDS DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 16. GLOBAL HIV/AIDS DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 17. GLOBAL HIV/AIDS DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 18. GLOBAL HIV/AIDS DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 19. GLOBAL HIV/AIDS DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 20. U.S. HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 21. U.S. HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 22. U.S. HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 23. CANADA HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 24. CANADA HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 25. CANADA HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 26. UK HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 27. UK HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 28. UK HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 29. GERMANY HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 30. GERMANY HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 31. GERMANY HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 32. ROE HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 33. ROE HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 34. ROE HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 35. CHINA HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 36. CHINA HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 37. CHINA HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 38. INDIA HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 39. INDIA HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 40. INDIA HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 41. JAPAN HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 42. JAPAN HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 43. JAPAN HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 44. ROAPAC HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 45. ROAPAC HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 46. ROAPAC HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 47. BRAZIL HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 48. BRAZIL HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 49. BRAZIL HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 50. MEXICO HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 51. MEXICO HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 52. MEXICO HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 53. ROLA HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 54. ROLA HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 55. ROLA HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 56. ROW HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 57. ROW HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 58. ROW HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)List of Figures
FIG 1. GLOBAL HIV/AIDS DIAGNOSTICS MARKET, RESEARCH METHODOLOGY
FIG 2. GLOBAL HIV/AIDS DIAGNOSTICS MARKET, MARKET ESTIMATION TECHNIQUES
FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4. GLOBAL HIV/AIDS DIAGNOSTICS MARKET, KEY TRENDS 2019
FIG 5. GLOBAL HIV/AIDS DIAGNOSTICS MARKET, GROWTH PROSPECTS 2020-2026
FIG 6. GLOBAL HIV/AIDS DIAGNOSTICS MARKET, PORTERS 5 FORCE MODEL
FIG 7. GLOBAL HIV/AIDS DIAGNOSTICS MARKET, PEST ANALYSIS
FIG 8. GLOBAL HIV/AIDS DIAGNOSTICS MARKET, VALUE CHAIN ANALYSIS
FIG 9. GLOBAL HIV/AIDS DIAGNOSTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 10. GLOBAL HIV/AIDS DIAGNOSTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 11. GLOBAL HIV/AIDS DIAGNOSTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 12. GLOBAL HIV/AIDS DIAGNOSTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 13. GLOBAL HIV/AIDS DIAGNOSTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 14. GLOBAL HIV/AIDS DIAGNOSTICS MARKET, REGIONAL SNAPSHOT 2016 & 2026
FIG 15. NORTH AMERICA HIV/AIDS DIAGNOSTICS MARKET 2016 & 2026 (USD BILLION)
FIG 16. EUROPE HIV/AIDS DIAGNOSTICS MARKET 2016 & 2026 (USD BILLION)
FIG 17. ASIA PACIFIC HIV/AIDS DIAGNOSTICS MARKET 2016 & 2026 (USD BILLION)
FIG 18. LATIN AMERICA HIV/AIDS DIAGNOSTICS MARKET 2016 & 2026 (USD BILLION)
FIG 19. GLOBAL HIV/AIDS DIAGNOSTICS MARKET, COMPANY MARKET SHARE ANALYSIS (2019)
Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report
Siemens Healthineers
Roche Diagnostics
Abbott Laboratories
Beckman Coulter, Inc.
Thermo-Fisher Scientific Inc.
Merck KGaA
Becton, Dickinson & Company
Hologic Inc.
Alere Inc.
Bio-Rad Laboratories
Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports

Publisher :